LOS ANGELES: An iPad application that can track and monitor cognitive function was released at the recent Alzheimer’s Association International Conference in Toronto by Quest Diagnostics, the giant diagnostic information services provider which generated revenue of $7.5 billion last year.
The app, called CogniSense, can be integrated into a patient’s electronic health record and be used along with laboratory and imaging testing to detect and diagnose dementia.